Quo Vadis (Where to), Illicit Drug Testing? Status, Developments, and Perspectives
Related Experiment Video
Updated: Nov 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Yordan Kostov1, Leonardo M Angelone1, Elena Koustova1
1Office of Translational Initiatives and Program Innovations (OTIPI), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), 31 Center Drive, Bld 31, Room 1B59D, Bethesda, Maryland20894, United States.
Abstract:
Drug testing is a critical tool used in many settings that span clinical care, employers, forensics, and law enforcement. It strives to accurately identify and quantify drugs with high addiction potential by utilizing the available analytical methods and sensors. This editorial offers an insight into the evolution of drug testing into its current set of methods and looks at the current trends that aim to transform the current practice, with a particular focus on the role of sensors and sensor-based devices. Unmet needs for different use cases are discussed, particularly the need for sensors capable of faster, lower-cost, and more specific detection at the point of need. An overview of the efforts in the state-of-the-art technologies that are developed while aiming to address these needs is presented. The paper aims to encourage further work on devices and sensors in the area and highlights the interests of NIDA.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Dependence

